Gene: PRKAR1B
Official Full Name: protein kinase cAMP-dependent type I regulatory subunit betaprovided by HGNC
Gene Summary: The protein encoded by this gene is a regulatory subunit of cyclic AMP-dependent protein kinase A (PKA), which is involved in the signaling pathway of the second messenger cAMP. Two regulatory and two catalytic subunits form the PKA holoenzyme, disbands after cAMP binding. The holoenzyme is involved in many cellular events, including ion transport, metabolism, and transcription. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03252 | PRKAR1B Knockout cell line (HeLa) | Human | PRKAR1B | 1:3~1:6 | Negative | Online Inquiry |
KO03253 | PRKAR1B Knockout cell line (HCT 116) | Human | PRKAR1B | 1:2~1:4 | Negative | Online Inquiry |
KO03254 | PRKAR1B Knockout cell line (HEK293) | Human | PRKAR1B | 1:3~1:6 | Negative | Online Inquiry |
KO03255 | PRKAR1B Knockout cell line (A549) | Human | PRKAR1B | 1:3~1:4 | Negative | Online Inquiry |
PRKAR1B Gene Knockout Cell Lines are engineered cell lines that have been specifically modified to disrupt the PRKAR1B gene, a critical component of the cAMP-dependent protein kinase (PKA) pathway. This gene is implicated in various cellular processes including cell growth, differentiation, and apoptosis. The knockout of PRKAR1B serves as a valuable tool for researchers seeking to understand the ramifications of altered cAMP signaling and its impact on various physiological and pathological conditions, such as cancer and cardiovascular diseases.
The primary function of PRKAR1B Gene Knockout Cell Lines is to facilitate the investigation of the gene's role in signaling pathways and cellular responses. By eliminating PRKAR1B expression, researchers can examine downstream effects, protein interactions, and alterations in cellular signaling. This provides a powerful mechanism for elucidating the specific contributions of PKA signaling in normal and disease states, as well as testing therapeutic strategies targeting these pathways.
The scientific importance of these cell lines extends to multiple disciplines, supporting research in fields such as oncology, endocrinology, and cardiology. Clinically, they can aid in the development of targeted therapies, allowing for the assessment of drug responses in a genetically controlled environment. This application is particularly pertinent in personalized medicine, where understanding individual genetic variations can lead to more effective treatments.
Compared to alternative models, PRKAR1B Gene Knockout Cell Lines offer a higher degree of specificity and reliability. While traditional pharmacological inhibitors may provide insights, they often lack the precision and context-specificity of genetic knockout models. Moreover, our cell lines are generated using state-of-the-art genome-editing technologies, ensuring optimal efficiency and reproducibility.
Researchers and clinicians will find remarkable value in these cell lines as they provide a robust system for testing hypotheses about cAMP signaling with unparalleled depth. As experts in the field of biological products, our company is committed to delivering high-quality research tools that empower scientific advancement. By utilizing PRKAR1B Gene Knockout Cell Lines, users can ensure their investigations are equipped with cutting-edge resources that facilitate breakthrough discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.